We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$2.55B
AUM Growth
+$20.3M
Cap. Flow
-$70.4M
Cap. Flow %
-2.76%
Top 10 Hldgs %
49.2%
Holding
64
New
1
Increased
27
Reduced
26
Closed
3

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$8.07M
2
QLYS icon
Qualys
QLYS
+$6.47M
3
CVLT icon
Commault Systems
CVLT
+$5.65M
4
CGNT icon
Cognyte Software
CGNT
+$4.7M
5
CRNC icon
Cerence
CRNC
+$4.31M

Sector Composition

Rank Sector Weight
1 Technology 45.42%
2 Healthcare 32.45%
3 Industrials 9.61%
4 Financials 7.21%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
1
Fortinet
FTNT
$117B
$174M 6.83%
3,565,240
-34,012
-0.9% -$1.77M
MANH icon
2
Manhattan Associates
MANH
$11.4B
$160M 6.28%
1,322,065
+2,065
+0.2% +$254K
IDXX icon
3
Idexx Laboratories
IDXX
$46.2B
$156M 6.12%
383,169
-178
-0% -$69.1K
ICLR icon
4
Icon
ICLR
$12.7B
$130M 5.08%
667,369
+817
+0.1% +$162K
AVAV icon
5
AeroVironment
AVAV
$9.45B
$125M 4.88%
1,453,469
-2,626
-0.2% -$225K
CYBR
6
DELISTED
CyberArk
CYBR
$113M 4.42%
870,813
+5,153
+0.6% +$745K
RMD icon
7
ResMed
RMD
$30.7B
$109M 4.26%
522,944
-2,012
-0.4% -$442K
NICE icon
8
Nice
NICE
$5.97B
$102M 4.01%
532,292
+2,616
+0.5% +$504K
FDS icon
9
Factset
FDS
$10.2B
$96M 3.76%
239,220
-6,565
-3% -$2.8M
MEDP icon
10
Medpace
MEDP
$16.5B
$91.3M 3.57%
429,663
-34,490
-7% -$6.89M
JKHY icon
11
Jack Henry & Associates
JKHY
$11.1B
$82.2M 3.22%
468,355
+1,310
+0.3% +$242K
QLYS icon
12
Qualys
QLYS
$6.35B
$78.5M 3.07%
699,506
+51,789
+8% +$6.47M
CGNX icon
13
Cognex
CGNX
$11.3B
$74.8M 2.93%
1,588,637
+6,155
+0.4% +$288K
TECH icon
14
Bio-Techne
TECH
$11.3B
$71.8M 2.81%
866,600
+101,616
+13% +$8.07M
ANSS
15
DELISTED
Ansys
ANSS
$70.3M 2.75%
291,171
-3,839
-1% -$894K
CSGP icon
16
CoStar Group
CSGP
$12.3B
$62.8M 2.46%
812,146
+19,794
+2% +$1.55M
GNTX icon
17
Gentex
GNTX
$5.07B
$58.6M 2.29%
2,147,341
-47,837
-2% -$1.28M
VRNT
18
DELISTED
Verint Systems
VRNT
$56.9M 2.23%
1,569,685
-54,627
-3% -$1.97M
VEEV icon
19
Veeva Systems
VEEV
$37.4B
$54.8M 2.15%
339,458
+4,572
+1% +$781K
KRNT icon
20
Kornit Digital
KRNT
$791M
$47.7M 1.87%
2,077,559
+29,416
+1% +$735K
ILMN icon
21
Illumina
ILMN
$28.4B
$46.4M 1.82%
235,887
-818
-0.3% -$170K
RBC icon
22
RBC Bearings
RBC
$18B
$41.5M 1.62%
198,073
+1,280
+0.7% +$292K
MORN icon
23
Morningstar
MORN
$7.53B
$39.9M 1.56%
184,448
+871
+0.5% +$199K
CRL icon
24
Charles River Laboratories
CRL
$12.8B
$36.8M 1.44%
169,000
-1,000
-0.6% -$218K
DXCM icon
25
DexCom
DXCM
$32B
$32M 1.25%
282,617
+1,943
+0.7% +$213K

Similar funds

American Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, American Capital Management held 64 positions worth $2.55B, up 0.8% from $2.53B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

American Capital Management's Q4 2022 filing shows 1 new, 27 increased, 26 reduced and 3 closed positions. Its largest new stake was Varonis Systems: 11,514 shares worth $276K. The largest sale was Abiomed Inc, an estimated $66.5M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q4 2022 buy was Varonis Systems: 11,514 shares worth $276K.
  • American Capital Management added most to Bio-Techne in Q4 2022, an estimated $8.07M increase.
  • American Capital Management's biggest Q4 2022 reduction was Kratos Defense & Security Solutions, cutting an estimated $8.73M.
  • American Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $66.5M.
  • American Capital Management's ten largest holdings make up 49% of its $2.55B portfolio in Q4 2022.
  • American Capital Management opened 1 new position and closed 3 in Q4 2022.
  • American Capital Management's portfolio value rose 0.8% quarter-over-quarter to $2.55B.

Based on American Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.